Novacyt S.A.
ALNOV.PA · PAR
Bulios Fair Price
0.25 €
49.2% downside
Trenutna cena
0.49 €
Po podatkih Bulios Fair Price je delnica ALNOV.PA trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Novacyt S.A. (ALNOV) is an international biotechnology company focused on the development, manufacturing, and distribution of diagnostic tests and reagents. The company specializes in molecular diagnostics, including tests for the detection of infectious diseases and genetic mutations. Novacyt plays a crucial role in the diagnostic industry, providing tools for rapid and accurate identification of various pathogens. Their technologies are utilized in healthcare, research, and other sectors. Novacyt S.A. focuses on innovation and the development of new diagnostic solutions. Investors interested in the biotechnology sector and healthcare innovations might see potential in Novacyt S.A. (ALNOV) shares for growth in this pivotal field.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Medical - Devices
CEO
Lyn Dafydd Rees
Employees
216
Headquarters
Le Vésinet
Prihajajoči dogodki
Earnings
Upcoming earnings report